Furthermore, as CREB3L1 silencing has been observed in lung squamous cell carcinoma, colon, adrenal gland, rectum, cervix, and liver cancers, the findings from this study may have broader implications beyond TNBC [31]. The gene discussed is CREB3L1; the disease is liver cancer.